Vol 83, No 3 (2025)
Clinical vignette
Published online: 2025-01-03
Long road to success. Endocardial radiofrequency ablation of septal hypertrophy using three-dimensional electroanatomic mapping guided by echocardiography in a patient with hypertrophic obstructive cardiomyopathy and severe aortic stenosis
Abstract
Not available
References
- Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 142(25): e533–e557.
- Mizia-Stec K, Burchardt P, Mazurkiewicz Ł, et al. Position statement of Polish Cardiac Society experts on cardiomyopathy. Pol Heart J. 2024; 82(10): 1040–1053.
- Lawrenz T, Lawin D, Radke K, et al. Acute and chronic effects of endocardial radiofrequency ablation of septal hypertrophy in HOCM. J Cardiovasc Electrophysiol. 2021; 32(10): 2617–2624.
- Cooper RM, Shahzad A, Hasleton J, et al. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation. Europace. 2016; 18(1): 113–120.
- Poon SS, Cooper RM, Gupta D. Endocardial radiofrequency septal ablation — A new option for non-surgical septal reduction in patients with hypertrophic obstructive cardiomyopathy (HOCM)?: A systematic review of clinical studies. Int J Cardiol. 2016; 222: 772–774.
